Cancer Risk After Medical Treatment
Michel P. Coleman(Author)
Oxford University Press
Published on 1. August 1991
Book
Hardback
199 pages
978-0-19-261781-1 (ISBN)
Description
"Cancer Risk After Medical Treatment" is a comprehensive review of recent research on cancer risk associated with various kinds of medical treatment. It covers radio-therapy and chemotherapy given for cancer and for other diseases, surgery, and the special case of survivors of a first cancer in childhood. It is aimed primarily at practising clinicians, to provide them with a review of cancer risks associated with the various treatment options available for serious disease, and to help them achieve the best balance of risk and benefit for each patient. It should also be of interest to research workers in epidemiology and basic clinical science for the insights it provides into cancer aetiology and the possibilities of devising more effective but less risky treatments. Perceptions of risk arising from medical treatment are often formed by rare but dramatic complications. This book provides a thorough and dispassionate review of all the evidence on one major group of diseases - the malignant neoplasms, or cancers - which may be caused by medical treatment, and sets these long-term but important risks against the immediate benefits obtained from the treatment.
More details
Language
English
Place of publication
Oxford
United Kingdom
Target group
College/higher education
Professional and scholarly
Illustrations
1 halftone, line drawings, tables, bibliography
Dimensions
Height: 230 mm
Width: 150 mm
Weight
490 gr
ISBN-13
978-0-19-261781-1 (9780192617811)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
Risk and benefit; radiation treatment for cancer - the induction of second malignancies; cancer after irradiation for non-malignant conditions; second malignancies following cytotoxic chemotherapy for cancer; chemotherapy and immunosuppression for non-malignant conditions; childhood malignancy; surgery; reducing the risk.